Leap Therapeutics Provides Update on BeiGene Option Agreement for DKN-01 By Investing.com
Leap Therapeutics (LPTX) Provides Update on BeiGene (BGNE) Option Agreement for DKN-01
Leap Therapeutics, Inc. (Nasdaq:NASDAQ:), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced…